Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Assets (2017 - 2025)

Historic Assets for Inmune Bio (INMB) over the last 9 years, with Q3 2025 value amounting to $33.4 million.

  • Inmune Bio's Assets fell 3680.04% to $33.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year decrease of 3680.04%. This contributed to the annual value of $39.6 million for FY2024, which is 3059.42% down from last year.
  • Latest data reveals that Inmune Bio reported Assets of $33.4 million as of Q3 2025, which was down 3680.04% from $37.7 million recorded in Q2 2025.
  • In the past 5 years, Inmune Bio's Assets ranged from a high of $107.7 million in Q3 2021 and a low of $33.4 million during Q3 2025
  • Its 5-year average for Assets is $65.6 million, with a median of $62.7 million in 2023.
  • Per our database at Business Quant, Inmune Bio's Assets soared by 16336.86% in 2021 and then plummeted by 3680.04% in 2025.
  • Over the past 5 years, Inmune Bio's Assets (Quarter) stood at $99.9 million in 2021, then dropped by 18.16% to $81.8 million in 2022, then plummeted by 30.31% to $57.0 million in 2023, then crashed by 30.59% to $39.6 million in 2024, then fell by 15.68% to $33.4 million in 2025.
  • Its last three reported values are $33.4 million in Q3 2025, $37.7 million for Q2 2025, and $37.8 million during Q1 2025.